COVID-19 Breakthrough Infection Among Vaccinated Population in the United Arab Emirates
Open Access
- 16 February 2023
- journal article
- research article
- Published by Springer Nature in Journal of Epidemiology and Global Health
- Vol. 13 (1) , 67-90
Abstract
Background Despite significant efforts to contain the Coronavirus Disease 2019 (COVID-19) pandemic through mass vaccination, numerous nations throughout the world have recorded breakout infections. The incidence and severity of COVID-19 breakthrough infections in the United Arab Emirates (UAE) remain unknown despite extensive COVID-19 vaccine coverage. The goal of this research is to establish the characteristics of COVID-19 breakthrough infections in the UAE’s vaccinated population. Methods Between February and March 2022, we conducted a descriptive cross-sectional study in the UAE with 1533 participants to examine the characteristics of COVID-19 breakthrough infection among the vaccinated population. Results The vaccination coverage was 97.97%, and the COVID-19 breakthrough infection rate was 32.1%, requiring hospitalization in 7.7% of cases. The bulk of the 492 COVID-19 breakthrough infections reported was among young adults (67%), with the majority experiencing mild to moderate symptoms (70.7%) or remaining asymptomatic (21.5%). Conclusions COVID-19 breakthrough infection were reported in younger age, male sex, non-healthcare professions, vaccination with inactivated whole virus vaccine (Sinopharm), and not receiving a booster dose. Information on breakthrough infection in the UAE might influence public health decisions and motivate measures such as providing additional booster doses of the vaccines to the people.Keywords
This publication has 27 references indexed in Scilit:
- UAE efforts in promoting COVID-19 vaccination and building vaccine confidenceVaccine, 2021
- Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) VariantNew England Journal of Medicine, 2021
- Decreased infectivity following BNT162b2 vaccination: A prospective cohort study in IsraelThe Lancet Regional Health - Europe, 2021
- Genomic survey of SARS-CoV-2 vaccine breakthrough infections in healthcare workers from Kerala, IndiaJournal of Infection, 2021
- Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individualsNature Medicine, 2021
- COVID-19 Vaccine Breakthrough Infections Reported to CDC — United States, January 1–April 30, 2021MMWR. Morbidity and Mortality Weekly Report, 2021
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infectionNature Medicine, 2021
- Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance dataThe Lancet, 2021
- Breakthrough COVID19 infections after vaccinations in healthcare and other workers in a chronic care medical facility in New Delhi, IndiaDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2021
- The Impact of Vaccination on Coronavirus Disease 2019 (COVID-19) Outbreaks in the United StatesClinical Infectious Diseases, 2021